This content is restricted.
Brief
The Drug Alert for October 2024 identifies multiple Not of Standard Quality (NSQ) drugs, revealing critical failures in sterility, assay, dissolution, particulate matter, and misbranding. The CDSCO’s monthly regulatory surveillance ensures that substandard pharmaceuticals are flagged for corrective action, emphasizing the importance of strict quality control in drug manufacturing.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested